{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:46:10Z","timestamp":1789076770624,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00198-014-2805-3","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T11:24:25Z","timestamp":1415964265000},"page":"35-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study"],"prefix":"10.1007","volume":"26","author":[{"given":"E.","family":"Van Caenegem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Taes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vandewalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Toye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"T\u2019Sjoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"2805_CR1","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1210\/jcem.86.10.7960","volume":"86","author":"E Seeman","year":"2001","unstructured":"Seeman E (2001) Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576\u201384","journal-title":"J Clin Endocrinol Metab"},{"key":"2805_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.1092190104","volume":"219","author":"HM Frost","year":"1987","unstructured":"Frost HM (1987) Bone \u201cmass\u201d and the \u201cmechanostat\u201d: a proposal. Anat Rec 219:1\u20139","journal-title":"Anat Rec"},{"key":"2805_CR3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/jbmr.1549","volume":"27","author":"M Nilsson","year":"2012","unstructured":"Nilsson M, Ohlsson C, Oden A, Mellstrom D, Lorentzon M (2012) Increased physical activity is associated with enhanced development of peak bone mass in men: a five-year longitudinal study. J Bone Miner Res 27:1206\u201314","journal-title":"J Bone Miner Res"},{"key":"2805_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/JOE-10-0209","volume":"207","author":"F Callewaert","year":"2010","unstructured":"Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D (2010) Skeletal sexual dimorphism: Relative contribution of sex steroids, GH-IGF1, and mechanical loading. J Endocrinol 207:127\u201334","journal-title":"J Endocrinol"},{"key":"2805_CR5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1359\/jbmr.081260","volume":"24","author":"B Lapauw","year":"2009","unstructured":"Lapauw B, Taes Y, Bogaert V, Vanbillemont G, Goemaere S, Zmierczak HG, De Bacquer D, Kaufman JM (2009) Serum estradiol and not testosterone influences volumetric bone mineral density and modulates the impact of physical activity on bone size at the age of peak bone mass\u2014a study in healthy male siblings. J Bone Miner Res 24:1075\u201385","journal-title":"J Bone Miner Res"},{"key":"2805_CR6","first-page":"E317","volume":"276","author":"JM Elbers","year":"1999","unstructured":"Elbers JM, Asscheman H, Seidell JC, Gooren LJ (1999) Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol 276:E317\u2013E325","journal-title":"Am J Physiol"},{"key":"2805_CR7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bone.2008.09.001","volume":"43","author":"B Lapauw","year":"2008","unstructured":"Lapauw B, Taes Y, Simoens S, Van Caenegem E, Weyers S, Goemaere S, Toye K, Kaufman JM, T\u2019Sjoen GG (2008) Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone 43:1016\u201321","journal-title":"Bone"},{"key":"2805_CR8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jocd.2008.11.002","volume":"12","author":"G T\u2019Sjoen","year":"2009","unstructured":"T\u2019Sjoen G, Weyers S, Taes Y, Lapauw B, Toye K, Goemaere S, Kaufman JM (2009) Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons. J Clin Densitom 12:306\u201313","journal-title":"J Clin Densitom"},{"key":"2805_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","volume":"54","author":"E Caenegem Van","year":"2013","unstructured":"Van Caenegem E, Taes Y, Wierckx K, Vandewalle S, Toye K, Kaufman JM, Schreiner T, Haraldsen I, T\u2019Sjoen G (2013) Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone 54:92\u201397","journal-title":"Bone"},{"key":"2805_CR10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","volume":"113","author":"R Dittrich","year":"2005","unstructured":"Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (2005) Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 113:586\u201392","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2805_CR11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.yhbeh.2007.05.012","volume":"52","author":"IR Haraldsen","year":"2007","unstructured":"Haraldsen IR, Haug E, Falch J, Egeland T, Opjordsmoen S (2007) Cross-sex pattern of bone mineral density in early onset gender identity disorder. Horm Behav 52:334\u201343","journal-title":"Horm Behav"},{"key":"2805_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.1.01943","volume":"153","author":"A Mueller","year":"2005","unstructured":"Mueller A, Dittrich R, Binder H, Kuehnel W, Maltaris T, Hoffmann I, Beckmann MW (2005) High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol 153:107\u201313","journal-title":"Eur J Endocrinol"},{"key":"2805_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0030-1255074","volume":"119","author":"A Mueller","year":"2011","unstructured":"Mueller A, Zollver H, Kronawitter D, Oppelt PG, Claassen T, Hoffmann I, Beckmann MW, Dittrich R (2011) Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 119:95\u2013100","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2805_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.5650040503","volume":"4","author":"P Lips","year":"1989","unstructured":"Lips P, Asscheman H, Uitewaal P, Netelenbos JC, Gooren L (1989) The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res 4:657\u201362","journal-title":"J Bone Miner Res"},{"key":"2805_CR15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2265.1998.00614.x","volume":"49","author":"S Reutrakul","year":"1998","unstructured":"Reutrakul S, Ongphiphadhanakul B, Piaseu N, Krittiyawong S, Chanprasertyothin S, Bunnag P, Rajatanavin R (1998) The effects of oestrogen exposure on bone mass in male to female transsexuals. Clin Endocrinol (Oxf) 49:811\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2805_CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-004-1754-7","volume":"16","author":"AG Ruetsche","year":"2005","unstructured":"Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K (2005) Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study. Osteoporos Int 16:791\u201398","journal-title":"Osteoporos Int"},{"key":"2805_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/JCD:6:3:297","volume":"6","author":"M Sosa","year":"2003","unstructured":"Sosa M, Jodar E, Arbelo E, Dominguez C, Saavedra P, Torres A, Salido E, de Tejada MJ, Hernandez D (2003) Bone mass, bone turnover, vitamin D, and estrogen receptor gene polymorphisms in male to female transsexuals: Effects of estrogenic treatment on bone metabolism of the male. J Clin Densitom 6:297\u2013304","journal-title":"J Clin Densitom"},{"key":"2805_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","volume":"48","author":"P Kesteren Van","year":"1998","unstructured":"Van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 48:347\u201354","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2805_CR19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635\u201342","journal-title":"Eur J Endocrinol"},{"key":"2805_CR20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2011","unstructured":"Coleman E, Bockting W, Botzer M, Cohen-Kettenis PT, De Cuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer W, Adler R, Brown G, Ehrbar R, Ettner R, Eyler E, Garofalo R, Karasic D, Lev AI, Mayer G, Meyer-Bahlburg H, Hall BP, Pfaefflin F, Rachlin K, Robinson B, Schechter L, Tangpricha V, van Trotsenburg M, Vitale A, Winter S, Whittle S, Wylie K, Zucker K (2011) Standards of care for the health of transsexual, transgender and gender nonconforming people. 7th edition. Int J Transgenderism 13:165\u2013232","journal-title":"Int J Transgenderism"},{"key":"2805_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eurpsy.2010.04.009","volume":"27","author":"BP Kreukels","year":"2012","unstructured":"Kreukels BP, Haraldsen IR, De Cuypere G, Richter-Appelt H, Gijs L, Cohen-Kettenis PT (2012) A European network for the investigation of gender incongruence: the ENIGI initiative. Eur Psychiatry 27:445\u201350","journal-title":"Eur Psychiatry"},{"key":"2805_CR22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/ajcn\/36.5.936","volume":"36","author":"JA Baecke","year":"1982","unstructured":"Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936\u201342","journal-title":"Am J Clin Nutr"},{"key":"2805_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","volume":"47","author":"PJ Kesteren Van","year":"1997","unstructured":"Van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 47:337\u2013342","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2805_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2012.02.034","volume":"893\u2013894","author":"T Fiers","year":"2012","unstructured":"Fiers T, Casetta B, Bernaert B et al (2012) Development of a highly sensitive method for the quantification of estrone and estradiol in serum by liquid chromatography tandem mass spectrometry without derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 893\u2013894:57\u201362","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2805_CR25","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00198-011-1632-z","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E (2011) Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 22:2789\u201398","journal-title":"Osteoporos Int"},{"key":"2805_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JES.0b013e318236e5ee","volume":"40","author":"KB Gunter","year":"2012","unstructured":"Gunter KB, Almstedt HC, Janz KF (2012) Physical activity in childhood may be the key to optimizing lifespan skeletal health. Exerc Sport Sci Rev 40:13\u201321","journal-title":"Exerc Sport Sci Rev"},{"key":"2805_CR27","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/00005768-200111000-00011","volume":"33","author":"K Delvaux","year":"2001","unstructured":"Delvaux K, Lefevre J, Philippaerts R, Dequeker J, Thomis M, Vanreusel B, Claessens A, Eynde BV, Beunen G, Lysens R (2001) Bone mass and lifetime physical activity in Flemish males: a 27-year follow-up study. Med Sci Sports Exerc 33:1868\u201375","journal-title":"Med Sci Sports Exerc"},{"key":"2805_CR28","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1210\/jc.2013-2198","volume":"98","author":"A Fujiyoshi","year":"2013","unstructured":"Fujiyoshi A, Polgreen LE, Hurley DL, Gross MD, Sidney S, Jacobs DR Jr (2013) A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study. J Clin Endocrinol Metab 98:4038\u201346","journal-title":"J Clin Endocrinol Metab"},{"key":"2805_CR29","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/jbmr.124","volume":"25","author":"A Chaitou","year":"2010","unstructured":"Chaitou A, Boutroy S, Vilayphiou N, Munoz F, Delmas PD, Chapurlat R, Szulc P (2010) Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study. J Bone Miner Res 25:2313\u201323","journal-title":"J Bone Miner Res"},{"key":"2805_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, Eisman LC, Fujiwara S, KrogerH MCEV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. OsteoporosInt 16:155\u2013162","journal-title":"OsteoporosInt"},{"key":"2805_CR31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","volume":"23","author":"S Khosla","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG (2012) Estrogen and the skeleton. Trends Endocrinol Metab 23:576\u201381","journal-title":"Trends Endocrinol Metab"},{"key":"2805_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00774-013-0466-5","volume":"32","author":"M Varsavsky","year":"2014","unstructured":"Varsavsky M, Reyes-Garcia R, Garcia-Martin A, Rozas-Moreno P, Rocio GR, Munoz-Torres M (2014) Bone turnover markers in patients with prostate carcinoma: Influence of sex steroids levels. J Bone Miner Metab 32:65\u201370","journal-title":"J Bone Miner Metab"},{"key":"2805_CR33","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1210\/jc.2002-020539","volume":"87","author":"P Taxel","year":"2002","unstructured":"Taxel P, Fall PM, Albertsen PC, Downset RD, Trahiotis M, Zimmerman J, Ohannessian C, Raisz LG (2002) The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer. J Clin Endocrinol Metab 87:4907\u201313","journal-title":"J Clin Endocrinol Metab"},{"key":"2805_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00298427","volume":"57","author":"S Eriksson","year":"1995","unstructured":"Eriksson S, Eriksson A, Stege R, Carlstrom K (1995) Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens. Calcif Tissue Int 57:97\u201399","journal-title":"Calcif Tissue Int"},{"key":"2805_CR35","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.juro.2012.11.016","volume":"189","author":"MR Smith","year":"2013","unstructured":"Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodrigez D, Hancock ML, Steiner MS (2013) Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol 189:S45\u201350","journal-title":"J Urol"},{"key":"2805_CR36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","volume":"106","author":"A Falahati-Nini","year":"2000","unstructured":"Falahati-Nini A, Riggs BL, Atkinson EJ, O\u2019Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553\u201360","journal-title":"J Clin Invest"},{"issue":"383(9912)","key":"2805_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","volume":"11","author":"IR Reid","year":"2014","unstructured":"Reid IR, Bolland MJ, Grey A (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 11(383(9912)):146\u201355","journal-title":"Lancet"},{"key":"2805_CR38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/JBMR.050404","volume":"20","author":"M Lorentzon","year":"2005","unstructured":"Lorentzon M, Swanson C, Andersson N, Mellstrom D, Ohlsson C (2005) Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study. J Bone Miner Res 20:1334\u201341","journal-title":"J Bone Miner Res"},{"key":"2805_CR39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jocd.2011.05.002","volume":"14","author":"G Rinaldi","year":"2011","unstructured":"Rinaldi G, Wisniewski CA, Setty NG, Leboff MS (2011) Peripheral quantitative computed tomography: Optimization of reproducibility measures of bone density, geometry, and strength at the radius and tibia. J Clin Densitom 14:367\u201373","journal-title":"J Clin Densitom"},{"key":"2805_CR40","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00198-012-2242-0","volume":"24","author":"RL Duckham","year":"2013","unstructured":"Duckham RL, Frank AW, Johnston JD, Olszynski WP, Kontulainen SA (2013) Monitoring time interval for pQCT-derived bone outcomes in postmenopausal women. Osteoporos Int 24:1917\u201322","journal-title":"Osteoporos Int"},{"key":"2805_CR41","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00198-008-0778-9","volume":"20","author":"EJ Marjanovic","year":"2009","unstructured":"Marjanovic EJ, Ward KA, Adams JE (2009) The impact of accurate positioning on measurements made by peripheral QCT in the distal radius. OsteoporosInt 20:1207\u20131214","journal-title":"OsteoporosInt"},{"key":"2805_CR42","doi-asserted-by":"crossref","unstructured":"Yu EW, Bouxsein M, Roy AE, Baldwin C, Cange A, Neer RM, Kaplan LM, Finkelstein JS (2013) Bone loss after bariatric surgery: Discordant results between DXA and QCT bone density. J Bone Miner Res","DOI":"10.1002\/jbmr.2063"},{"key":"2805_CR43","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S8756-3282(01)00503-8","volume":"29","author":"S Goemaere","year":"2001","unstructured":"Goemaere S, Van Pottelbergh I, Zmierczak H, Toye K, Daems M, Demuynck R, Myny H, De Bacquer D, Kaufman JM (2001) Inverse association between bone turnover rate and bone mineral density in community-dwelling men >70\u00a0years of age: No major role of sex steroid status. Bone 29:286\u201391","journal-title":"Bone"},{"key":"2805_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/JME-09-0165","volume":"45","author":"J Svensson","year":"2010","unstructured":"Svensson J, Moverare-Skrtic S, Windahl S, Swanson C, Sjogren K (2010) Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways. J Mol Endocrinol 45:45\u201357","journal-title":"J Mol Endocrinol"},{"key":"2805_CR45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25:693\u2013721","journal-title":"Endocr Rev"},{"key":"2805_CR46","first-page":"3267","volume":"82","author":"JM Elbers","year":"1997","unstructured":"Elbers JM, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJ (1997) Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 82:3267\u201370","journal-title":"J Clin Endocrinol Metab"},{"key":"2805_CR47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","volume":"369","author":"JS Finkelstein","year":"2013","unstructured":"Finkelstein JS, Lee H, Burnett-Bowie S-AAM, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ (2013) Gonadal steroids and body composition, strength, and sexual function in men. NEJM 369:1011\u20131022","journal-title":"NEJM"},{"key":"2805_CR48","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87:1586\u201392","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2805-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2805-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T06:43:13Z","timestamp":1566024193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2805"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2805-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,7]]}}}